PRESS RELEASES

RAYMEDICA® WORKSHOP OFFERS LATEST CONCEPTS & CLINICAL EXPERIENCE OF THE HYDRAFLEX™ NUCLEUS ARTHROPLASTY™ TECHNOLOGY

MINNEAPOLIS - April 26, 2007 - Raymedica, the Pioneer in Nucleus Arthroplasty, announced today that Dr. med. univ. Rudolf Bertagnoli, Spine Surgeon and Past President of the Spine Arthroplasty Society (SAS) and the industry honored Prof. Dr. Hans-Joachim Wilke, Institute of Orthopaedic Research and Biomechanics, University of Ulm, will co-moderate the Raymedica one-day “Workshop” at the Spine Arthroplasty Society 7th (SAS7) Annual Conference at the Maritim Hotel in Berlin, Germany on May 2nd, 2007, Salon 16, Riga Room at 12:30 – 2:00 PM.

“I would like to thank the industry professionals and our prestigious workshop moderators for contributing their services to this year's Raymedica SAS7 Workshop,” commented John J. Viscogliosi, Chairman and Chief Executive Officer. “It is a real privilege to see this Workshop come into existence with the extraordinary cooperation of these award winning individuals.”

About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus Arthroplasty having developed the world’s first nucleus replacement device in 1996. Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have been unresponsive to non-surgical treatment. Raymedica’s products are currently available in many countries worldwide, but are limited to investigational use only in the United States. For more information, visit the Company's website at http://www.raymedica.com.

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
 
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.


> Back to Press Releases

 

Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.